Champlain Investment Partners’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,600
Closed -$63K 120
2019
Q4
$63K Hold
13,600
﹤0.01% 119
2019
Q3
$63K Hold
13,600
﹤0.01% 119
2019
Q2
$64K Hold
13,600
﹤0.01% 117
2019
Q1
$58K Hold
13,600
﹤0.01% 120
2018
Q4
$53K Hold
13,600
﹤0.01% 119
2018
Q3
$62K Buy
13,600
+2,400
+21% +$11.4K ﹤0.01% 118
2018
Q2
$52K Hold
11,200
﹤0.01% 120
2018
Q1
$81K Hold
11,200
﹤0.01% 123
2017
Q4
$72K Hold
11,200
﹤0.01% 116
2017
Q3
$74K Hold
11,200
﹤0.01% 112
2017
Q2
$61K Buy
+11,200
New +$63.9K ﹤0.01% 117
2015
Q4
Sell
-90,000
Closed -$441K 139
2015
Q3
$441K Hold
90,000
0.01% 127
2015
Q2
$549K Buy
+90,000
New +$556K 0.01% 124

Other funds holding ABEV

Champlain Investment Partners's ABEV Position: Q1 2020 in Review

Champlain Investment Partners sold out of Ambev (ABEV) in Q1 2020, closing a stake of 13,600 shares — an estimated $63K sold.

Champlain Investment Partners first reported a position in ABEV in Q2 2015 and held it in 13 quarters. The position peaked at $549K in Q2 2015. 277 funds tracked by Wall St. Rank hold ABEV as of Q1 2020.

  • Champlain Investment Partners reported no remaining Ambev position as of Q1 2020 after selling out during the quarter.
  • Champlain Investment Partners sold 13,600 Ambev shares in Q1 2020, an estimated $63K.
  • Champlain Investment Partners first reported a position in Ambev in Q2 2015 and held it in 13 quarters.
  • Champlain Investment Partners's Ambev position peaked at $549K in Q2 2015.
  • 277 funds tracked by Wall St. Rank held Ambev as of Q1 2020.

Based on Champlain Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.